Verve Therapeutics, Inc. Uncategorized Contracts & Agreements

4 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Description of Securities Registered under Section 12 of the Exchange Act
Verve Therapeutics, Inc.
Biotechnology
2022
Offer Letter, dated as of July 26, 2019, by and between the Registrant and Andrew Bellinger, M.D., Ph.D
Verve Therapeutics, Inc.
Biotechnology
2021
Offer Letter, dated as of July 26, 2019, by and between the Registrant and Andrew Ashe, J.D
Verve Therapeutics, Inc.
Biotechnology
2021
Offer Letter, dated as of April 16, 2019, by and between the Registrant and Sekar Kathiresan, M.D
Verve Therapeutics, Inc.
Biotechnology
MA
2021